
zzso was zzso in 1984 at the laboratory of zzso zzso Phase I study of zzso was begun in zzso The appropriate doses for phase II studies were decided to be 100 zzso weekly or 150 zzso every 2 zzso Phase II study was conducted and this drug was approved for zzso zzso zzso cancer and zzso cancer by zzso in zzso It obtained approval for stomach cancer, zzso cancer, breast cancer, skin cancer and zzso zzso in zzso The combination zzso including zzso have been conducted by using various regimens such as zzso + zzso zzso + zzso zzso + zzso and zzso + zzso In stage IV zzso two prospective zzso controlled trials are on going comparing zzso zzso zzso + zzso zzso zzso + zzso and zzso + zzso zzso zzso + zzso In advanced zzso Japanese Clinical Oncology Group zzso started a zzso controlled trial comparing zzso + zzso zzso zzso + zzso In stage III zzso the dose escalation studies of zzso zzso in the combination with zzso are ongoing by zzso The problem of zzso in the combination chemotherapy and combined zzso is that it is quite difficult to increase the dose of zzso to full dose to obtain the maximum zzso 

